Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.32 USD | -0.25% | +1.61% | +21.81% |
Mar. 07 | Kewaunee Scientific Shares Fall After Company Posts Lower Fiscal Q3 Net Sales | MT |
Mar. 06 | Earnings Flash (KEQU) KEWAUNEE SCIENTIFIC CORPORATION Posts Q3 Revenue $46.8M | MT |
Financials (USD)
Sales 2022 | 169M | Sales 2023 | 219M | Capitalization | 45.99M |
---|---|---|---|---|---|
Net income 2022 | -6M | Net income 2023 | - | EV / Sales 2022 | 0.44 x |
Net Debt 2022 | 34.36M | Net Debt 2023 | 33.62M | EV / Sales 2023 | 0.36 x |
P/E ratio 2022 |
-6.48
x | P/E ratio 2023 |
65
x | Employees | 982 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.33% |
1 day | -1.09% | ||
1 week | +1.61% | ||
Current month | +2.94% | ||
1 month | +10.66% | ||
3 months | +22.31% | ||
6 months | +96.18% | ||
Current year | +21.81% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Hull
CEO | Chief Executive Officer | 48 | 15-10-31 |
Donald Gardner
DFI | Director of Finance/CFO | 45 | 19-04-28 |
Mandar Ranade
CTO | Chief Tech/Sci/R&D Officer | 50 | 19-12-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Rhind
CHM | Chairman | 61 | 08-03-31 |
Donald Shaw
BRD | Director/Board Member | 73 | 13-05-31 |
Keith Gehl
BRD | Director/Board Member | 65 | 15-04-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 35.41 | -1.09% | 3 342 |
24-04-17 | 35.8 | +2.20% | 6,765 |
24-04-16 | 35.03 | +0.52% | 16,153 |
24-04-15 | 34.85 | +1.90% | 8,350 |
24-04-12 | 34.2 | -1.87% | 3,361 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+21.81% | 102M | |
+9.90% | 7.3B | |
+2.47% | 2.89B | |
+0.26% | 2.84B | |
-1.36% | 1.95B | |
+4.08% | 1.39B | |
-12.50% | 1.36B | |
-20.07% | 465M | |
-2.18% | 437M | |
-10.68% | 398M |
- Stock Market
- Equities
- KEQU Stock